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Impaired Preadipocyte Differentiation in Human
Abdominal Obesity
Role of Wnt, Tumor Necrosis Factor-, and Inﬂammation
Petter Isakson, Ann Hammarstedt, Birgit Gustafson, and Ulf Smith
OBJECTIVE—We examined preadipocyte differentiation in
obese and nonobese individuals and the effect of cytokines and
wingless-type MMTV (mouse mammary tumor virus) integration
site family, member 3A (Wnt3a) protein on preadipocyte differ-
entiation and phenotype.
RESEARCH DESIGN AND METHODS—Abdominal subcuta-
neous adipose tissue biopsies were obtained from a total of 51
donors with varying BMI. After isolation of the adipose and
stromalvascular cells, inﬂammatory cells (CD14- and CD45-
positive cells) were removed by immune magnetic separation.
CD133-positive cells, containing early progenitor cells, were also
isolated and quantiﬁed. The CD14- and CD45-negative preadipo-
cytes were cultured with tumor necrosis factor (TNF)-, inter-
leukin (IL)-6, resistin, or Wnt3a with or without a differentiation
cocktail.
RESULTS—The number of preadipocytes able to differentiate to
adipose cells was negatively correlated with both BMI and
adipocyte cell size of the donors, whereas the number of
CD133-positive cells was positively correlated with BMI, suggest-
ing an impaired differentiation of preadipocytes in obesity.
Cultured preadipocytes, like freshly isolated mature adipocytes,
from obese individuals had an increased expression of mitogen-
activated protein 4 kinase 4 (MAP4K4), which is known to inhibit
peroxisome proliferator–activated receptor- induction. TNF-,
but not IL-6 or resistin, increased Wnt10b, completely inhibited
the normal differentiation of the preadipocytes, and instead
induced a proinﬂammatory and macrophage-like phenotype of
the cells.
CONCLUSIONS—The apparent number of preadipocytes in the
abdominal subcutaneous tissue that can undergo differentiation
is reduced in obesity with enlarged fat cells, possibly because of
increased MAP4K4 levels. TNF- promoted a macrophage-like
phenotype of the preadipocytes, including several macrophage
markers. These results document the plasticity of human prea-
dipocytes and the inverse relationship between lipid storage and
proinﬂammatory capacity. Diabetes 58:1550–1557, 2009
I
n adult humans, the increased adipose tissue mass in
obesity mainly leads to an expansion of the size of
the prevailing adipose cells (1,2). However, there is
also a continuous turnover of the adipose cells, and
thus recruitment of new adipocytes (2–4).
The development of insulin resistance and its complica-
tions are predominantly seen in conjunction with abdom-
inal adipose tissue distribution and associated cell
enlargement (hypertrophic or abdominal/upper-body obe-
sity) rather than peripheral obesity, which is usually
associated with a recruitment of new preadipocytes and
thus small adipose cells (hyperplastic or peripheral/lower-
body obesity) (5–7).
An important consequence of adipose cell enlargement
is the development of local inﬂammation in the adipose
tissue with inﬁltration of monocytes/macrophages (8,9).
The reason for this is currently unclear but may be
attributable to adipose cell death, where macrophages can
be seen as scavengers of remaining debris and lipids (10).
In addition, adipose cell enlargement leads to increased
secretion of cytokines and chemokines, which in turn
attract monocytes/macrophages into the tissue (11–14).
Both mechanisms may well be operative, and, in addition,
local activation of the macrophages in the adipose tissue
plays a key role (15), but the tissue factors involved are
currently unknown.
Obesity-associated inﬂammation leads to highly dys-
regulated adipose tissue with an altered pattern of se-
creted adipokines and increased lipolysis (rev. in 14,16).
Secretion of cytokines like tumor necrosis factor (TNF)-
in the adipose tissue impairs the differentiation of preadi-
pocytes, reduces adiponectin secretion, and promotes a
proinﬂammatory state, which in turn further promotes the
local secretion of cytokines and chemokines (17,18). In
addition, both interleukin (IL)-6 and TNF- induce insulin
resistance in the adipose cells at the level of insulin
signaling and action because of reduced expression of
insulin receptor substrate-1 and GLUT4 (17,19).
Obesity, both in animal models and in humans, is
associated with an increase in different markers of inﬂam-
matory cells, such as CD68, macrophage inﬂammatory
protein (MIP)-1, EMR (epidermal growth factor–like
module containing mucin-like hormone receptor), and
ADAM-8 (a disintegrin and metalloproteinase domain-8) in
the adipose tissue (rev. in 14,18,20). In fact, using such
markers, Weisberg et al. (8) reported that up to 50% of the
cells in the adipose tissue were positive for CD68 and thus
could be classiﬁed as macrophages. They also reported
that the CD68-positive cells were the major producers of
the different cytokines studied (8).
From the Lundberg Laboratory for Diabetes Research, Center of Excellence
for Metabolic and Cardiovascular Research, Department of Molecular and
Clinical Medicine, the Sahlgrenska Academy at the University of Gothen-
burg, Gothenburg, Sweden.
Corresponding author: Ulf Smith, ulf.smith@medic.gu.se.
Received 19 December 2008 and accepted 24 March 2009.
Published ahead of print at http://diabetes.diabetesjournals.org on 7 April
2009. DOI: 10.2337/db08-1770.
© 2009 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
1550 DIABETES, VOL. 58, JULY 2009Although there is no doubt that macrophages are
present in the adipose tissue in obesity, it is highly unlikely
that they could account for up to 50% of the cells. This
raises the question of whether other cells present in the
adipose tissue can also become positive for macrophage
markers and under what conditions. However, several
studies with human preadipocytes cultured in vitro have
been unable to ﬁnd these cells positive for CD68 or other
macrophage markers (21). Nevertheless, both gene arrays
and the report that 3T3-L1 cells injected into the peritoneal
cavity of mice assumed a macrophage-like phenotype
(22,23) support the close link between preadipocytes and
macrophages.
Here, we asked whether human undifferentiated preadi-
pocytes cultured in vitro could assume a macrophage-like
phenotype if they were activated by proinﬂammatory
molecules (TNF, IL-6, or resistin). During the course of the
experiments, we also we found that the number of prea-
dipocytes in subcutaneous abdominal adipose tissue that
differentiated to adipose cells was negatively correlated
with BMI as well as mean adipose cell size of the donors.
A potential mechanism for this may be increased mitogen-
activated protein 4 kinase 4 (MAP4K4) expression in
preadipocytes from obese individuals because MAP4K4
inhibits peroxisome proliferator–activated receptor
(PPAR)- activation as well as adipogenesis (24,25).
RESEARCH DESIGN AND METHODS
Abdominal subcutaneous adipose tissue was obtained from 51 different
subjects by needle biopsy (n  45) or bariatric surgery (n  6). This
procedure was approved by the ethical committee of the University of
Gothenburg. Subjects were between 28 and 69 years of age and had a BMI
(mean  SE) of 28.8  2.2 kg/m
2 (range 19.3–54.8).
Preadipocyte culture. Adipose tissue was digested with collagenase as
previously reported and cell size measured (19). The medium under the
isolated adipocytes was collected and centrifuged for 10 min at 200g. The cell
pellet was washed twice and the erythrocytes were lysed with 155 mmol/l
NH4Cl for 5 min before seeding the cells in a 55-cm
2 petri dish. After 3 days,
when the cells had started to proliferate, the progenitor or inﬂammatory cells
were isolated with magnetic immune separation. The remaining cells were
then cultured at 37°C with Dulbecco’s modiﬁed Eagle’s medium (DMEM) and
Ham’s F12 (1:1) with 10% fetal bovine serum (FBS), 2 mmol/l glutamine, 100
units/ml penicillin, and 100 g/ml streptavidin. After 2 weeks cells were
trypsinized and any remaining inﬂammatory cells removed by magnetic
immune separation of CD14- and CD45-positive cells (Miltenyi Biotech,
Bergisch Gladbach, Germany). The remaining preadipocyte fraction was
seeded (10,000 cells/cm
2) and cultured in six-well plates (Nunc, Roskilde,
Denmark). Cells were left untreated or grown in the presence of 5 ng/ml
TNF-, 20 ng/ml IL-6, 50 ng/ml resistin, or 10 ng/ml lipopolysaccharide for 10
days. In some experiments, 300 mol/l oleic acid was added to the medium for
48 h after 10 days of culture.
Differentiation of the preadipocytes was induced with a differentiation
cocktail consisting of 850 nmol/l insulin, 10 mol/l dexamethasone, 0.5 mmol/l
IBMX (isobutylmethylxanthine), 10 mol/l pioglitazone, 33 mol/l biotin, and
17 mol/l pathenonate in DMEM/F12 supplemented with 3% FBS (vol/vol), 2
mmol/l glutamine, and antibiotics. After 3 days, the medium was changed to a
medium containing only insulin, dexamethasone and pioglitazone in DMEM/
F12, 10% FBS with glutamine, and antibiotics. (Human preadipocytes require
the continuous presence of a thiazolidinedione to remain differentiated.) The
cells were then left to differentiate for another 18 days with medium changed
every other day. In some experiments 5 ng/ml TNF-, 20 ng/ml IL-6, 50 ng/ml
wingless-type MMTV (mouse mammary tumor virus) integration site family,
member 3A (Wnt3a), or 50 ng/ml resistin was added to the differentiation
medium.
Oil red O staining. To determine lipid accumulation, cells cultured in
six-well plates were ﬁxed with 10% formalin for 20 min and then stained with
oil red O for 60 min. Optical density for oil red O was determined by washing
the stained cells carefully, and, after removal of all water, 1 ml isopropanol
was added to each well. The plates were left for 10 min and optical density
measured at 510 nm. The absorbance of cells that had undergone differenti-
ation was then related to that of undifferentiated cells ( 1).
Isolation of CD133-positive cells. After trypsin treatment, the total number
of cells were counted in a hemocytometer and then labeled and isolated with
magnetic beads against CD133. The CD133-enriched cell fraction was counted
and the number of CD133-positive cells calculated.
Real-time PCR. RNA was isolated with RNeasy (Qiagen, Hilden, Germany),
and 10 ng total RNA was used for cDNA synthesis using a high-capacity cDNA
reverse-transcription kit (Applied Biosystems, Foster City, CA). An ABI Prism
7900 sequence detection system (Applied Biosystems) was used to analyze
gene expression. On-demand primers and probes (Applied Biosystems) or
custom-designed reagents were used. The sequences are available on request.
For real-time PCR, 10 ng cDNA, 100 nmol/l probes, and 200 nmol/l of both
reverse as well as forward primers were used and the procedure was per-
formed as recommended by the manufacturer. Relative quantiﬁcation of
mRNA levels was plotted as the fold change compared with the basal state,
using 18S rRNA as endogenous control (Applied Biosystems).
Enzyme-linked immunosorbent assay. Secreted cytokines and chemokines
(IL-1, IL-6, IL-8, and monocyte chemoattractant protein [MCP]-1) were
determined in the cell culture medium by enzyme-linked immunosorbent
assay (ELISA) techniques according to the manufacturer’s instructions (Bio-
source, Carlsbad, CA). Secretion of granulocyte-macrophage–colony-stimu-
lating factor (GM-CSF), serum amyloid A (SAA), and intercellular adhesion
molecule (ICAM) was measured by multiplex electrochemiluminescence
using Meso Scale Discovery technology (Gaithersburg, MD), and levels of
TNF- were measured by high-sensitivity human TNF- Quantikine ELISA
(R&D Systems, Minneapolis, MN).
Acetylated LDL uptake. Cells were washed with PBS and incubated with
medium containing 10 g/ml Dil-Ac-LDL (Invitrogen, Carlsbad, CA) for4ha t
37°C. After incubation, cells were washed with PBS and ﬁxed with 3% formalin
for 10 min. Fluorescence was visualized using standard rhodamine excitation/
emission ﬁlters. Human primary macrophages were used as positive controls.
Statistical analyses. All statistical analyses were performed with SPSS
version 11 programs. Wilcoxon’s nonparametric test for paired observations
was used to evaluate differences between the different conditions. P  0.05
was considered statistically signiﬁcant.
RESULTS
Impaired differentiation of abdominal subcutaneous
preadipocytes from obese subjects. We plated the
remaining stromal-vascular cells after the CD14- and
CD45-positive inﬂammatory cells had been removed by
magnetic immune separation. After addition of the differ-
entiation cocktail, the CD14- and CD45-negative cells
accumulated lipids, and the expression of adiponectin and
GLUT4 was increased (Fig. 1A), showing that these cells
indeed were preadipocytes.
The number of preadipocytes that differentiated varied
markedly between the patients and ranged from 20 to 90%
(Fig. 1B). Interestingly, there was a highly signiﬁcant
negative correlation between BMI of the donor and num-
ber of preadipocytes differentiating to adipocytes, as re-
ﬂected by oil red O accumulation (Fig. 1C). Although the
results shown in Fig. 1C also included ﬁve type 2 diabetic
individuals, the results were virtually identical when these
were excluded from the analyses (r  0.594, P  0.01, n 
20, vs. r  0.549, P  0.01, n  15). Negative correlation
was also found between preadipocyte differentiation and
average adipocyte size of the donors (Fig. 1D), which in
turn is a marker of insulin sensitivity (5–8).
The negative correlation between BMI, cell size, and
number of preadipocytes able to differentiate can either be
attributable to a reduced number of preadipocytes in the
abdominal adipose tissue in obesity and/or to an impaired
ability of these cells to differentiate. One reason could be
fewer progenitor cells, including mesenchymal stem cells,
which undergo commitment to preadipocytes in vivo. To
address this, we isolated CD133-positive cells because we
(unpublished data) and others (26,27) have shown that
this population contains pluripotent cells that can be
differentiated to adipose, bone, and muscle cells.
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FIG. 1. Impaired differentiation of human preadipocytes from obese donors. A: mRNA expression of GLUT4 and adiponectin (Apm1) before (  1)
and after (f) adipocyte differentiation. Data are the means  SE from six different subjects. *P < 0.05. B: Oil red O staining (absorbance) of primary
human preadipocytes differentiated for 21 days from two different donors with varying percentage of differentiation. C: BMI of the preadipocyte donor
is signiﬁcantly and inversely correlated to the degree of preadipocyte differentiation (R
2  0.59, P  0.006). D: Correlation between preadipocyte
differentiation and mean adipocyte size of the donors (R
2  0.69, P < 0.001). E: The relative number of CD133-positive cells in the stromal vascular
fraction is positively correlated with BMI of the donor (R
2  0.51, P < 0.01). F: mRNA levels of MAP4K4 in cultured preadipocytes in relation to BMI
of the donors (R
2  0.42, P < 0.05). G and H: Correlation between MAP4K4 mRNA levels in isolated mature adipose cells and BMI (R
2  0.41, P < 0.04)
(G) or waist-to-hip ratio (WHR) (H) of the donors (R
2  0.67, P  0.002). Abs, absorbance; RQ, relative quantiﬁcation.
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cells in the stromal vascular fraction was positively corre-
lated with BMI (r  0.7141, P  0.01, n  10) (Fig. 1E).
This positive correlation seemed to plateau at higher BMI
because we also studied an individual with BMI 66 kg/m
2
in whom 1.8% of the cells were CD133 positive. Thus, it
appears that the pool of early adipocyte precursor cells is
not reduced but, rather, that commitment is impaired
and/or committed preadipocytes from obese individuals
have an impaired ability to differentiate to the adipocyte
phenotype.
We examined the expression of several different genes
in the undifferentiated preadipocytes from obese versus
nonobese individuals and found that expression of
MAP4K4 in the preadipocytes was positively correlated
with BMI (r  0.647, P  0.05) (Fig. 1F). This kinase has
previously been shown to impair adipogenesis, to be
induced by TNF-, and to inhibit PPAR- expression
(24,25). To examine whether this increase was induced by
the culture procedure, we examined MAP4K4 mRNA lev-
els in freshly isolated mature adipose cells. MAP4K4 was
also increased in these cells and the expression correlated
with both BMI (Fig. 1G) and the waist-to-hip ratio of the
donor (Fig. 1H). Waist-to-hip ratio is a well-established
marker of the metabolic complications of obesity, includ-
ing insulin resistance (5–8). Thus, increased MAP4K4
seems to be an intrinsic property of the (pre)adipocytes in
obesity characterized by enlarged fat cells.
TNF and Wnt3a, but not resistin or IL-6, inhibit
human preadipocyte differentiation. When TNF- was
added, the CD14- and CD45-negative stromal vascular cells
became more densely packed, suggesting a proliferating
and/or antiapoptotic effect of TNF- (Fig. 2A). However,
no cell underwent normal differentiation with lipid accu-
mulation (Fig. 2B), and this was also supported by the lack
of induction of mRNA of the differentiation markers
adiponectin and GLUT4 (Fig. 2C). Similar to TNF-, addi-
tion of the Wnt ligand Wnt3a completely prevented the
differentiation of these cells (Fig. 2B).
Addition of TNF- to undifferentiated 3T3-L1 cells has
been shown to activate the Wnt pathway and Wnt10b
expression (18,28). We also found in human preadipocytes
that Wnt10b was increased in the presence of TNF- (Fig.
2C), whereas Wnt3a was not expressed (data not shown).
In contrast to TNF-, addition of either IL-6 or resistin did
not prevent normal differentiation of the cells or increase
gene expression of Wnt10b (data not shown). Thus, of the
tested cytokines, TNF- alone completely prevented the
normal differentiation of human preadipocytes, activated
Wnt10b expression, and, probably as a consequence, also
seemed to enhance the proliferation of these cells.
The inhibitory effect of TNF- is reversible. We then
asked whether the inhibitory effect of TNF- was transient
or whether an associated activation of the Wnt pathway
could contribute to a long-term inability of the preadipo-
cytes to become adipose cells and thus explain this
negative correlation with BMI. TNF- was removed from
the incubation medium after 10 days and differentiation
induced with the normal cocktail. However, the effect of
TNF- seems to be rapidly reversible because the cells
accumulated lipids to a similar degree as the control cells,
which had not been exposed to TNF- (Fig. 2D). Further-
more, they started to express differentiation markers as
rapidly as the control cells, albeit at a lower level (data not
shown).
Human preadipocytes assume a macrophage-like
phenotype in the presence of TNF- or lipopolysac-
charide. We next examined the gene expression of undif-
ferentiated preadipocytes that had been exposed or not
exposed to TNF-, IL-6, or resistin for 10 days. In the
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FIG. 2. TNF- and Wnt3a inhibit the differentiation of human preadipocytes. A: The presence of TNF- induces proliferation of primary human
preadipocytes. B: The presence of either TNF- (5 ng/ml) or Wnt3a (50 ng/ml) completely prevented normal adipocyte differentiation, as shown
by oil red O staining. C: mRNA expression of GLUT4, adiponectin (Apm1), and Wnt10 after adipocyte differentiation for 21 days in the absence
() or presence of TNF- (5 ng/ml) (f). Data are the means  SE from 11 different subjects. *P < 0.05. D: Oil red O staining of human
preadipocytes differentiated for 21 days with or without preincubation with TNF- (5 ng/ml) for 10 days. Bas, basal; RQ, relative quantiﬁcation.
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matory phenotype associated with increased expression of
cytokines and chemokines (Tables 1 and 2). Most impor-
tantly, genes that were not expressed or only expressed at
very low levels in the basal state became activated by
TNF-. These included GM-CSF, IL-1, MIP-1, TNF-
itself, CD68, and matrix metalloprotease 3 (MMP3) (Table
1). Signiﬁcant upregulation was also seen of proinﬂamma-
tory molecules already expressed in the preadipocytes,
like IL-6, IL-8, MCP-1, SAA, ICAM, MMP7, and toll-like
receptor (TLR)-2, but not TLR4 (Table 2). Again, neither
IL-6 nor resistin induced any signiﬁcant changes in these
genes (Tables 1 and 2).
We also measured the secretion of several cytokines and
chemokines and found increases in secretion that paral-
leled the gene expression pattern (Fig. 3). Again, IL-1,
which was not secreted, and GM-CSF, which was secreted
at very low levels in the nonstimulated cells, were clearly
induced by TNF- (Fig. 3). TNF- also increased the
secretion of IL-6, IL-8, MCP-1, SAA, and ICAM. However,
we found no consistent secretion of TNF- itself, as
measured in the medium of cells where TNF- had been
removed from the medium after 10 days (data not shown),
indicating a lack of activation of TACE (TNF- converting
enzyme). Thus, these partially transdifferentiated preadi-
pocytes still lack endogenous TNF- secretion.
We also tested whether lipopolysaccharide can alter the
phenotype of these cells and found, in general, similar
changes as with TNF-. There were no additive effects of
combining lipopolysaccharide and TNF-, suggesting that
they inﬂuenced the same pathways (data not shown).
We then examined whether the cells also became phago-
cytotic or expressed the scavenger receptor. However, we
were unable to see the induction of a phagocytotic poten-
tial (data not shown). Although acetylated LDL uptake was
slightly increased by the presence of TNF-, only a few
cells (5%) were positive for LDL uptake. Thus, a com-
plete transdifferentiation of the cells into macrophages,
including phagocytotic potential, secretion of TNF-, and
expression of the scavenger receptor, was not seen.
Effect of oleic acid. Because TNF- did not alter TLR4
expression, we asked whether the addition of fatty acids
to the medium—a normal component in vivo—would
further contribute to the transdifferentiation of the cells.
Addition of 300 mol/l oleic acid to the medium for 48 h
increased lipid droplet formation in the cells but did not
further alter the pattern of transdifferentiation seen in the
presence of TNF- alone (data not shown).
DISCUSSION
Many studies have shown that the secretion of IL-6,
MCP-1, and other cytokines/chemokines by human adi-
pose tissue mainly emanate from the stromal vascular
cells (29,30). The ﬁnding that macrophages inﬁltrate the
adipose tissue in obesity has led to the conclusion that
these cells are the main source of cytokine/chemokine
secretion (8,9), although recent studies have shown that
mature adipose cells also secrete IL-6 and MCP-1 (11,29).
The role of the inﬂammatory cells has been supported by
reports that different markers of macrophages, such as
CD68, are highly prevalent (up to 50% of the cells in the
adipose tissue expressing this marker) and positively
related to the size of the adipose cells (8).
CD68 and MIP-1 have been used in many studies to
indicate the number/presence of macrophages in the adi-
pose tissue, and a negative correlation between CD68
mRNA expression and insulin sensitivity in vivo has been
found in humans (31). Thus, it appears that CD68 expres-
sion and other markers of macrophages in the adipose
TABLE 1
Effect of TNF-, IL-6, and resistin on mRNA levels of macrophage-related genes in preadipocytes
Basal
TNF- IL-6 Resistin
Mean P value Mean P value Mean P value
GM-CSF 1.0  0.0 50  29 0.004 1.0  0.1 NS 1.1  0.1 NS
IL-1 1.0  0.0 305  148 0.003 1.7  0.4 NS 1.3  0.2 NS
MIP-1 1.0  0.0 804  432 0.003 0.9  0.2 NS 1.1  0.2 NS
TNF- 1.0  0.0 3.3  0.4 0.003 1.1  0.2 NS 1.5  0.5 NS
CD68 1.0  0.0 3.4  0.9 0.03 1.0  0.1 NS 1.1  0.2 NS
MMP3 1.0  0.0 59  39 0.003 2.1  0.8 NS 1.0  0.1 NS
Data are means  SE where basal is set to 1. Human preadipocytes in the stromal vascular fraction were cultured for 10 days with or without
5 ng/ml TNF-, 20 ng/ml IL-6, or 50 ng/ml human resistin. n  11.
TABLE 2
Effect of TNF-, IL-6, and resistin on gene expression in undifferentiated human preadipocytes
Basal
TNF- IL-6 Resistin
Mean P Mean P Mean P
IL-6 1.0  0.0 4.3  0.7 0.003 1.0  0.1 NS 1.2  0.1 NS
IL-8 1.0  0.0 777  344 0.003 1.6  0.2 NS 8.5  7.9 NS
MCP-1 1.0  0.0 6.2  2.1 0.016 1.1  0.2 NS 1.2  0.2 NS
SAA1 1.0  0.0 13.1  6.1 (0.09) 1.1  0.2 NS 1.1  0.1 NS
SAA2 1.0  0.0 7.7  3.5 (0.09) 1.2  0.3 NS 1.1  0.1 NS
ICAM 1.0  0.0 113  107 0.003 1.3  0.1 NS 1.4  0.3 NS
MMP7 1.0  0.0 3.9  0.9 0.02 0.9  0.2 NS 2.4  0.8 NS
TLR2 1.0  0.0 7.1  0.7 0.003 0.9  0.1 NS 1.5  0.3 NS
TLR4 1.0  0.0 2.5  1.0 NS 1.0  0.1 NS 1.2  0.2 NS
Data are means  SE where basal is set to 1. The same experimental conditions were used as in Table 1. n  11.
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individuals. However, the current study clearly shows that
CD68, MIP-1, or other commonly used markers cannot be
considered dependable indicators of the number of mac-
rophages, but rather that they reﬂect the degree of inﬂam-
mation in the tissue. In this context, it should be added
that it is highly unlikely that any macrophages were
present in the cultures as a confounding factor. First, we
initially removed the CD14- and CD45-positive cells
through magnetic immune separation of the cells, and,
second, it is highly unlikely that any macrophages would
have survived the culture procedures in this medium
extending, in total, 3–4 weeks.
We examined the ability of human preadipocytes, ob-
tained from the abdominal subcutaneous tissue of differ-
ent individuals, to differentiate to adipose cells and the
role of TNF-, IL-6, and resistin on differentiation and
phenotypic development. The salient ﬁndings were that 1)
there was a very large interindividual difference in the
number of cells capable of differentiating into adipocytes,
and the differentiation capability was negatively correlated
with BMI as well as the average adipocyte size of the
donors and, thus, insulin sensitivity; 2) MAP4K4 expres-
sion in adipocytes and cultured preadipocytes was posi-
tively correlated with BMI; 3) TNF-, but not IL-6 or
resistin, completely prevented the normal differentiation
of the preadipocytes into adipose cells; and 4) TNF-
promoted a partial transdifferentiation of the preadipo-
cytes to assume a macrophage-like phenotype. This effect,
at least under the short-term conditions used, was revers-
ible and dependent on the continuous presence of TNF-
because the cells were not induced to secrete TNF-
themselves. Lipopolysaccharide also prevented the normal
differentiation, as also previously reported (21), but
lipopolysaccharide does not contribute above and be-
yond the effect of TNF-. This latter point was also
supported by our ﬁndings that activation of TLR4 with
oleic acid (32) did not further enhance the TNF-–
induced partial transdifferentiation.
Our ﬁnding of a reduced number of preadipocytes in
abdominal subcutaneous adipose tissue in obesity is in
agreement with recent work by Permana et al. (33) and
Tchoukalova et al. (34). These latter authors (34) also
identiﬁed and quantiﬁed preadipocytes in the stromal-
vascular cells through the positive expression of aP2, or
FABP4 (fatty acid binding protein 4), but negative expres-
sion of CD68. Using these markers in freshly isolated cells,
it was reported in a small study (n  3) that obese
individuals may have up to a 50% reduction in the apparent
number of preadipocytes in the abdominal subcutaneous
adipose tissue, but this was not seen in a peripheral
(lateral thigh) depot (34). However, a problem with the
interpretation of these data are the exclusion of CD68-
positive cells, which would also exclude potential preadi-
pocytes, which are inhibited by the proinﬂammatory
environment. Thus, it is still an open question whether the
number of preadipocytes is reduced in abdominal subcu-
taneous adipose tissue in obesity or whether the negative
correlation with BMI and adipocyte size that we found
mainly reﬂects an inability of the preadipocytes to undergo
normal differentiation when the adipose cells expand in
obesity. It should be emphasized that we cultured the
preadipocytes in the presence of thiazolidinediones to
fully promote adipogenesis. Thus, the differences in ability
to differentiate cannot be related to lack of endogenous
ligand formation.
In contrast to the reduced apparent number of preadi-
pocytes, we found that the pool of potential precursor
cells, identiﬁed through magnetic immune separation with
the CD133 marker (26,27), was positively correlated to
BMI. This suggests that there is a speciﬁc problem for
preadipocytes in abdominal subcutaneous adipose tissue
to differentiate into normal adipocytes and/or for the
commitment of progenitor cells to preadipocytes. This is a
very intriguing ﬁnding that could explain why there is
differential lipid partitioning and also why abdominal
obesity is closely linked to insulin resistance and the
accumulation of ectopic fat in the liver and expanded fat
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FIG. 3. Human preadipocytes assume a macrophage-like phenotype in the presence of TNF-. Levels of secreted inﬂammatory molecules by human
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P. ISAKSON AND ASSOCIATES
DIABETES, VOL. 58, JULY 2009 1555depots in the epicardial and visceral depots (rev. in 35).
Our results also suggest that this inability is not attribut-
able to the inhibitory effect of TNF- per se on differenti-
ation because we found that this effect is rapidly reversible
and dependent on the continuous presence of TNF-
secreted by the macrophages. However, it may well be that
chronically elevated TNF- levels (or other unknown
molecules) in the adipose tissue in obesity can, for in-
stance, via MAP4K4 and/or Wnt signal activation, lead to a
complete transdifferentiation or dedifferentiation of the
preadipocytes to another phenotype, including inﬂamma-
tory cells. Interestingly, we found that cultured preadipo-
cytes from obese individuals had higher expression of
MAP4K4, a kinase induced by TNF- that inhibits the
induction of PPAR- as well as adipogenesis (24,25). It is
indeed intriguing that preadipocytes from obese individu-
als maintain elevated MAP4K4 expression, despite the
long culture period. Interestingly, MAP4K4 expression in
freshly isolated adipose cells was also positively related
to BMI as well as the waist-to-hip ratio—a well-known
marker of the metabolic abnormalities associated with
obesity (5–7). Thus, this seems to be an intrinsic effect in
adipose tissue in obesity and involves both preadipocytes
and mature adipose cells.
The enlarged adipose cells in obesity become dysregu-
lated (14,16) with reduced expression of many PPAR-–
regulated genes, including GLUT4 and adiponectin.
Instead, inﬂammatory genes are increased. This dysregu-
lated state may be a consequence of reduced PPAR-
activation, including the transrepression of proinﬂamma-
tory genes. We do not currently understand the molecular
mechanisms for this apparent partial loss of PPAR-
activation, but ongoing studies where MAP4K4 is knocked
down in human preadipocytes may shed new light on
these intriguing ﬁndings.
An additional possibility that needs to be considered is
that there is a slow, continuous turnover of adipose cells
(10% per year) (12) and that this depletes the number of
available preadipocytes in the adipose tissue in obesity.
However, this would seem to be particularly important for
obesity characterized by hyperplastic adipose tissue, and
this is usually not associated with abdominal adipose cell
enlargement, insulin resistance, and inﬂammation.
We have previously described in 3T3-L1 preadipocytes
that TNF- completely prevents the normal differentiation
and that it is associated with an activation of Wnt 10b and
the Wnt signaling cascade (18,36). Similar to the current
study, we did not ﬁnd any effect of resistin or MCP-1 on
Wnt signaling in 3T3-L1 cells (36), and thus this seems to
be speciﬁc for TNF-. A direct activation of the Tcf/Lef
(T-cell–speciﬁc transcription factor/lymphoid-enhancer
binding factor) nuclear receptor by TNF- has also re-
cently been reported (28). Thus, TNF- maintains preadi-
pocytes in an undifferentiated state while, concomitantly,
it is able to drive the cells toward a macrophage-like
phenotype.
Intriguingly, we found that TNF- induced the expres-
sion and secretion of molecules that were not expressed
or secreted by the preadipocytes, such as GM-CSF and
IL-1. In addition, the cells assumed a marked proinﬂam-
matory phenotype with the induction of both markers
(SAA and ICAM) and effectors (IL-6, MCP-1, and IL-8) of
inﬂammation. Overall, the cells became highly macro-
phage-like, with the exception of phagocytotic capacity,
expression of the scavenger receptor, or secretion of
TNF- itself. Thus, the partially transformed and proin-
ﬂammatory preadipocytes would seem to be an important
source for maintaining, and enhancing, inﬂammation both
in the adipose tissue in obesity as well as systemically
because many of the secreted molecules are released to
the bloodstream (SAA, ICAM, IL-6, IL-8, and MCP-1).
Furthermore, the undifferentiated preadipocytes/macro-
phage-like cells started to induce and secrete GM-CSF.
Thus, inﬁltrating macrophages can both drive inﬂamma-
tion in the adipose tissue/preadipocytes and also induce a
milieu whereby bound monocytes will undergo differenti-
ation to macrophages in the tissue.
To evaluate the potential quantitative importance of
the undifferentiated human preadipocytes for MCP-1 se-
cretion by the adipose tissue, we compared our results
with those reported in the literature. MCP-1 secretion
by adipose tissue from obese individuals was estimated
by Dahlman et al. (11) to 23 ng/g tissue  h or 23 ng/10
6
cells  h, assuming an average cell size of 0.8 g/cell. In
the current study, the secretion of MCP-1 by preadipocytes
cultured in the presence of TNF- was 200 ng/2.5 	 10
5
cells  4 8ho r17 ng/10
6 cells  h. Thus, activated
preadipocytes may indeed be the major source of MCP-1
secretion by adipose tissue. Again, using the results re-
ported by Dahlman et al. (11), it is clear that mature
adipose cells only account for 2–5% of the MCP-1 pro-
duced by adipose tissue. Published data (29,30) for IL-6
and -8 secretion by adipose tissue also lead to the conclu-
sion that undifferentiated preadipocytes can be the major
source of secretion of these cytokines.
In conclusion, these ﬁndings underscore the importance
of partially transdifferentiated preadipocytes as generators
of inﬂammation in obesity. These effects appear to be
speciﬁc to TNF-; at least they are not shared by IL-6,
MCP-1, or resistin. Furthermore, obesity with subcutane-
ous abdominal adipose cell enlargement is characterized
by a reduced number of preadipocytes that can undergo
differentiation. Understanding the mechanisms for this
and the cross-talk between TNF- and Wnt signaling is a
priority because it may open up new possibilities to treat
obesity with regards to inﬂammation, preadipocyte re-
cruitment, and insulin sensitivity.
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